Learn More
BIOHIPPO InVivoMAb Anti-Human CCL14/NCC-2 (Iv0082), 100 µg

Supplier: BIOHIPPO BHA21409914
CCL14/NCC-2 Recombinant Antibody (clone Iv0082) is a recombinant Human IgG1, kappa antibody specific for CCL14/NCC-2. It reacts with Human. Suitable for ELISA, Neutralization. Recombinant production ensures high specificity and lot-to-lot reproducibility. Supplied as 100 ug.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.